Showing results (391-400 of 418) with videos related to
Sort By:
Pageof 42
Nano Letters|October 15, 2014
Magnetic mesocrystal-assisted magnetoresistance in manganiteJan-Chi Yang, Qing He, Yuan-Min Zhu, et al.Journal of Surgical Oncology|February 13, 2023
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG OncologyMark L Kayton, Aaron R Weiss, Wei Xue, et al.Research Square|January 30, 2023
Heterogeneity in the M. tuberculosis β-Lactamase Inhibition by SulbactamMarius Schmidt, Tek Narsingh Malla, Kara Zielinski, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 4, 2026
Phase 1 trial of pre-operative image guided intensity modulated photon radiotherapy with simultaneously integrated boost to the high-risk margin for patients with retroperitoneal sarcomaKevin X Liu, Yen-Lin Chen, Beow Y Yeap, et al.Proceedings of the National Academy of Sciences of the United States of America|April 21, 2021
Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertensionZdravka Daneva, Corina Marziano, Matteo Ottolini, et al.Science Signaling|March 3, 2021
A venous-specific purinergic signaling cascade initiated by Pannexin 1 regulates TNFα-induced increases in endothelial permeabilityDaniela Maier-Begandt, Heather Skye Comstra, Samuel A Molina, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Prognostic Significance of Percentage and Size of Dedifferentiation in Dedifferentiated ChondrosarcomaYin P Hung, Ivan Chebib, Miriam A Bredella, et al.Nature Communications|September 7, 2023
Heterogeneity in M. tuberculosis β-lactamase inhibition by SulbactamTek Narsingh Malla, Kara Zielinski, Luis Aldama, et al.Journal of Surgical Oncology|June 27, 2020
Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicityBrian C Baumann, Karen De Amorim Bernstein, Thomas F DeLaney, et al.Diagnostics (Basel, Switzerland)|July 27, 2022
Improving the Diagnostic Performance by Adding Methylation Marker to Conventional Visual Examination in Identifying Oral CancerCheng-Chieh Yang, Yee-Fun Su, Han-Chieh Cheng, et al.Pageof 42